HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheng Hu Selected Research

alpha-solamargine

1/2022Solasonine Inhibits Pancreatic Cancer Progression With Involvement of Ferroptosis Induction.
9/2020Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheng Hu Research Topics

Disease

64Type 2 Diabetes Mellitus (MODY)
08/2021 - 02/2007
32Neoplasms (Cancer)
01/2022 - 08/2010
27Insulin Resistance
03/2022 - 02/2007
19Obesity
01/2022 - 01/2007
14Non-alcoholic Fatty Liver Disease
07/2022 - 04/2013
13Inflammation (Inflammations)
07/2022 - 12/2016
11Wounds and Injuries (Trauma)
08/2022 - 12/2019
10Prostatic Neoplasms (Prostate Cancer)
01/2021 - 12/2011
9Infections
07/2022 - 01/2018
8Pancreatitis
05/2022 - 07/2017
8Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2021 - 06/2009
6Neoplasm Metastasis (Metastasis)
01/2022 - 09/2018
6Diabetic Nephropathies (Diabetic Nephropathy)
01/2022 - 01/2015
6Hyperglycemia
01/2021 - 08/2007
5Metabolic Diseases (Metabolic Disease)
01/2022 - 01/2015
5Glucose Intolerance
06/2021 - 01/2015
5Hypertension (High Blood Pressure)
06/2021 - 05/2011
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2019
5Weight Loss (Weight Reduction)
01/2019 - 10/2015
4Fatty Liver
10/2021 - 01/2021
4Acute Liver Failure (Fulminant Hepatic Failure)
01/2021 - 05/2019
4Diabetes Complications
01/2019 - 11/2008
3Albuminuria
01/2022 - 01/2015
3Atherosclerosis
01/2022 - 05/2015
3Abdominal Obesity
01/2022 - 01/2016
3Gestational Diabetes (Gestational Diabetes Mellitus)
08/2021 - 01/2017
3Carcinoma (Carcinomatosis)
01/2021 - 08/2010
3Thrombosis (Thrombus)
01/2021 - 01/2020
3Infertility (Sterility)
01/2021 - 10/2019
3Dyslipidemias (Dyslipidemia)
01/2020 - 08/2007
3Overweight
09/2015 - 03/2012
2Disease Progression
07/2022 - 05/2022
2Fibrosis (Cirrhosis)
07/2022 - 01/2021
2Chronic Pancreatitis
05/2022 - 01/2017
2Neuralgia (Stump Neuralgia)
05/2022 - 04/2022
2Pain (Aches)
04/2022 - 01/2021
2Neuroinflammatory Diseases
04/2022 - 01/2022
2Reperfusion Injury
01/2022 - 01/2020
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2022 - 01/2020
2Weight Gain
01/2022 - 01/2018
2Hyperuricemia
01/2022 - 04/2019

Drug/Important Bio-Agent (IBA)

32Glucose (Dextrose)FDA LinkGeneric
07/2022 - 02/2007
18Proteins (Proteins, Gene)FDA Link
07/2022 - 04/2010
18Pharmaceutical PreparationsIBA
05/2022 - 09/2007
13LipidsIBA
07/2022 - 04/2013
12Insulin (Novolin)FDA Link
01/2022 - 08/2008
10Biomarkers (Surrogate Marker)IBA
07/2022 - 05/2015
9HydrogelsIBA
08/2022 - 10/2020
9Uric Acid (Urate)IBA
01/2022 - 01/2015
7CytokinesIBA
04/2022 - 01/2017
7Blood Glucose (Blood Sugar)IBA
03/2022 - 11/2008
6Triglycerides (Triacylglycerol)IBA
07/2022 - 01/2016
5AcidsIBA
08/2022 - 01/2016
5CholesterolIBA
07/2022 - 06/2009
5Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021 - 05/2019
5repaglinide (Prandin)FDA Link
03/2016 - 08/2008
4Antiviral Agents (Antivirals)IBA
01/2022 - 01/2018
4CreatinineIBA
01/2022 - 01/2015
4Bile Acids and Salts (Bile Acids)IBA
01/2022 - 01/2018
4fibroblast growth factor 21IBA
10/2021 - 01/2014
4MicellesIBA
07/2021 - 01/2020
4MicroRNAs (MicroRNA)IBA
01/2021 - 12/2016
4Therapeutic UsesIBA
08/2020 - 08/2008
4HaptoglobinsIBA
11/2019 - 01/2018
4Peptides (Polypeptides)IBA
01/2019 - 08/2010
4Gliclazide (Diamicron)IBA
01/2018 - 10/2014
4Rosiglitazone (Avandia)FDA Link
03/2016 - 09/2007
3CollagenIBA
08/2022 - 12/2021
3AntioxidantsIBA
07/2022 - 01/2017
3Collagen Type III (Type III Collagen)IBA
01/2022 - 12/2021
3Amyloid (Amyloid Fibrils)IBA
01/2022 - 07/2013
3Biological ProductsIBA
01/2022 - 06/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 08/2010
3Fatty Acids (Saturated Fatty Acids)IBA
10/2021 - 01/2016
3Indicators and Reagents (Reagents)IBA
08/2021 - 01/2015
3Androgen Receptors (Androgen Receptor)IBA
01/2021 - 01/2019
3ChemokinesIBA
01/2021 - 12/2017
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 12/2017
3AntigensIBA
01/2021 - 10/2003
3ophiopogonin BIBA
01/2021 - 09/2018
3LDL CholesterolIBA
01/2019 - 01/2014
3C-PeptideIBA
11/2016 - 08/2007
2Hyaluronic Acid (Hyaluronan)IBA
08/2022 - 01/2022
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2022 - 01/2012
2LDL Lipoproteins (beta Lipoproteins)IBA
07/2022 - 01/2019
2AlbuminsIBA
07/2022 - 04/2018
2Growth Differentiation Factor 15IBA
03/2022 - 07/2017
2alpha-solamargineIBA
01/2022 - 09/2020
2Apolipoproteins E (ApoE)IBA
01/2022 - 01/2016

Therapy/Procedure

20Therapeutics
07/2022 - 09/2007
7Drug Therapy (Chemotherapy)
04/2022 - 01/2018
6Gastric Bypass (Roux-en-Y Gastric Bypass)
08/2019 - 04/2016
5Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021 - 09/2018
4Injections
08/2022 - 01/2018
4Electroacupuncture
01/2022 - 01/2020
4Bariatric Surgery
01/2020 - 10/2015
4Castration
01/2020 - 10/2016
3Immunotherapy
01/2021 - 08/2010
3Glycemic Control
01/2021 - 05/2015
3Intravenous Injections
07/2018 - 12/2017